✦ LIBER ✦
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials
✍ Scribed by Charles B Hicks; Pedro Cahn; David A Cooper; Sharon L Walmsley; Christine Katlama; Bonaventura Clotet; Adriano Lazzarin; Margaret A Johnson; Dietmar Neubacher; Douglas Mayers; Hernan Valdez
- Book ID
- 117299678
- Publisher
- The Lancet
- Year
- 2006
- Tongue
- English
- Weight
- 124 KB
- Volume
- 368
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.